NKGen Biotech (NKGN) said Tuesday it expects its shares to be traded on the OTC Markets starting Wednesday following its delisting from Nasdaq.
The company said Nasdaq determined to delist its shares after the close of trading on March 4 due to its continued failure to comply with the market value rule.
NKGen said it has cancelled its 1-for-6 reverse stock split plan.
NKGen shares fell over 48% in recent trading.
Price: 0.26, Change: -0.25, Percent Change: -49.11
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.